Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
West Pharmaceutical Services revenue increased from $1.8 billion in 2019 to $2.1 billion in 2020, a (16.7%) increase.

Annual Revenue ($)

West Pharmaceutical Services revenue was $2.15 b in FY, 2020 which is a (16.7%) year over year increase from the previous period.

Quarterly Revenue ($)

FY, 2018FY, 2019FY, 2020
Revenue$1.72 b$1.84 b$2.15 b
Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021
Revenue$443.5 m$469.7 m$456.1 m$491.5 m$527.2 m$548 m$670.7 m$723.6 m

Annual Growth Rate (%)

Revenue Breakdown

Business Segment

Geographic Segment

West Pharmaceutical Services revenue breakdown by business segment: 23.2% from Contract-Manufactured Products and 76.8% from Proprietary Products

West Pharmaceutical Services revenue breakdown by geographic segment: 45.4% from United States, 10.5% from Ireland, 13.1% from Germany, 8.0% from France, 11.0% from Other European countries and 11.8% from Other

FY, 2020FY, 2019FY, 2018
Proprietary Products1.65 b441.5 m1.31 b
Contract-Manufactured Products498.6 m1.4 b409.1 m
FY, 2020FY, 2019FY, 2018
United States975.6 m814.7 m766.1 m
Germany282.1 m236.3 m235.9 m
France172.7 m150.6 m127.5 m
Other European countries236.8 m251.1 m386.1 m
Other253.7 m213.4 m201.8 m
Ireland226 m173.8 m

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.

Footer menu